Autobahn’s elunetirom receives FDA fast track designation to treat adjunctive bipolar

Elunetirom is designed to enhance neurobiological activity at CNS-TRs and reduce peripheral thyroid hormone-related risks. Credit: sasirin pamai / Shutterstock.com.